Tejara Capital’s Integra LifeSciences IART Stock Holding History

Tejara Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.82M	Buy	193,313 +21,500	+13%	+$236K	0.6%	52
2025 Q4	$2.13M	Buy	171,813 +51,300	+43%	+$682K	0.5%	34
2025 Q3	$1.73M	Sell	120,513 -7,873	-6%	-$108K	0.9%	32
2025 Q2	$1.58M	Buy	128,386 +73,386	+133%	+$1.07M	0.73%	43
2025 Q1	$1.21M	Buy	+55,000	New	+$1.29M	0.47%	50

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tejara Capital's IART Position: Q1 2026 in Review

Tejara Capital increased its Integra LifeSciences (IART) stake by 13% in Q1 2026, buying an estimated $236K and bringing the position to 193,313 shares worth $1.82M. The position accounts for 0.6% of the portfolio, ranked #52.

Tejara Capital first reported a position in IART in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.13M in Q4 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Tejara Capital held 193,313 shares of Integra LifeSciences worth $1.82M as of Q1 2026.
Tejara Capital bought 21,500 Integra LifeSciences shares in Q1 2026, an estimated $236K.
Integra LifeSciences made up 0.6% of Tejara Capital's portfolio in Q1 2026, its #52 holding.
Tejara Capital first reported a position in Integra LifeSciences in Q1 2025 and has held it in 5 quarters since.
Tejara Capital's Integra LifeSciences position peaked at $2.13M in Q4 2025.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Tejara Capital's 13F filing for Q1 2026, filed 12 May 2026.